Glenmark Pharma gets nod for favipiravir; Cipla, Hetero for remdesivir

·

·

Glenmark Pharma gets nod for favipiravir; Cipla, Hetero for remdesivir

Two vital drugs to treat Covid-19 patients got the drug regulator’s nod on Friday. While Glenmark Pharma got the Drug Controller General of India’s (DCGI’s) approval to launch oral antiviral favipiravir, Maharashtra Health Minister Rajesh Tope claimed Cipla …
See Original Article

Wall Street dips as virus fears drown out economy hopes

NEW YORK — Wall Street careened through all the forces that have pushed and pulled it through the week, at first rising on Friday amid hope for the economy and then falling on worries about worsening coronavirus levels in some states, all before ending …
See Original Article

Mass. reports 30 new deaths; number of ICU patients drops below 200

BOSTON – The Massachusetts Department of Public Health reported 30 new COVID-19-related deaths across the state Friday, bringing the state’s total to 7,800. In addition, state health officials reported 228 new confirmed and probable COVID-19 cases, …
See Original Article

Johnson & Johnson Will Stop Selling Skin-Whitening Lotions

The consumer-products giant Johnson & Johnson said on Friday that it would no longer sell certain products that are advertised as dark-spot reducers but have been used by some purchasers to lighten skin tone. The product lines, Neutrogena Fine Fairness …
See Original Article

UPDATE 1-FedEx to record about $370 mln in charges in fourth quarter

(Adds details from FedEx’s filing). June 19 (Reuters) – U.S. package delivery company FedEx Corp said www.sec.gov/ix?doc=/Archives/edgar/data/1048911/000119312520174218/d949507d8k.htm on Friday it would record non-cash asset impairment …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.